Issue link: https://read.uberflip.com/i/1503820
T A B L E 3 Within‐groups over time Baseline Post‐ intervention Follow‐up Baseline—post‐test within‐groups Effect sizes [95% CI] Baseline—follow‐up within‐groups Effect sizes [95% CI] Mean (SD) Mean (SD) Mean (SD) t(df) = , p Hedge's g t(df) = , p Hedge's g HADS‐total iCBT 17.12 (7.12) 12.79 (7.42) 11.00 (5.87) t(37) = 2.74, p = 0.009** 0.59 [0.16, 1.02] t(29) = 3.96, p = 0.000** 0.91 [0.43, 1.38] Control 16.09 (5.60) 16.42 (6.48) 17.00 (6.90) t(18) = −0.72, p = 0.483 −0.05 [−0.66, 0.55] t(16) = −0.57, p = 0.574 −0.08 [−0.74, 0.57] HADS‐anxiety iCBT 10.67 (4.22) 8.53 (4.60) 7.57 (3.85) t(37) = 2.46, p = 0.019* 0.48 [0.05, 0.91] t(29) = 3.67, p = 0.000** 0.75 [0.28, 1.22] Control 9.96 (3.15) 10.79 (4.01) 10.82 (4.82) t(18) = −1.05, p = 0.307 −0.23 [−0.84, 0.38] t(16) = −0.49, p = 0.629 −0.21 [−0.84, 0.41] HADS‐depression iCBT 6.45 (3.99) 4.26 (3.48) 3.43 (2.78) t(37) = 2.40, p = 0.022* 0.57 [0.14, 1.01] t(29) = 3.32, p = 0.002** 0.83 [0.36, 1.31] Control 6.13 (3.44) 5.63 (3.24) 6.18 (2.90) t(18) = −0.17, p = 0.866 0.15 [−0.46, 0.75] t(16) = −0.49, p = 0.633 −0.02 [−0.64, 0.61] QOL iCBT 4.69 (1.39) 5.24 (1.00) 5.57 (0.94) t(37) = −1.89, p = 0.066 −0.44 [−0.87, −0.01] t(29) = −4.63, p = 0.000** −0.33 [−0.82, 0.15] Control 4.83 (1.30) 5.11 (1.29) 5.29 (1.26) t(18) = −0.72, p = 0.480 −0.21 [−0.82, 0.40] t(16) = −1.49, p = 0.155 −0.14 [−0.79, 0.52] CWC iCBT 16.82 (4.50) 14.66 (4.15) 14.30 (3.68) t(37) = 2.57, p = 0.015* 0.49 [0.06, 0.92] t(29) = 3.17, p = 0.004** 0.59 [0.13, 1.06] Control 15.91 (3.63) 15.21 (4.05) 16.29 (4.96) t(18) = 0.77, p = 0.453 0.18 [−0.43, 0.79] t(16) = 0.63, p = 0.951 −0.23 [−0.89, 0.42] Active coping iCBT 2.60 (0.52) 2.83 (0.49) 2.96 (0.59) t(37) = −1.33, p = 0.192 −0.45 [−0.88, −0.02] t(29) = −1.63, p = 0.113 −0.24 [−0.72, 0.24] Control 2.72 (0.49) 2.61 (0.56) 2.64 (0.45) t(18) = 1.27, p = 0.219 0.21 [−0.40, 0.82] t(16) = 0.561, p = 0.583 −0.06 [−0.71, 0.60] Avoidant coping iCBT 1.99 (0.44) 1.92 (0.44) 1.87 (3.34) t(37) = 0.92, p = 0.366 0.16 [−0.27, 0.58] t(29) = 2.12, p = 0.043* 0.06 [−0.40, 0.51] Control 1.97 (3.34) 1.88 (0.42) 1.96 (0.47) t(18) = 0.76, p = 0.459 0.04 [−0.57, 0.64] t(16) = 0.25, p = 0.807 −0.18 [−0.83, 0.48] MOS‐SSS iCBT 3.35 (0.88) 3.40 (1.07) 3.45 (0.92) t(37) = −0.14, p = 0.889 −0.05 [−0.47, 0.37] t(29) = −1.55, p = 0.133 −0.05 [−0.53, 0.43] Control 2.97 (0.97) 3.03 (0.94) 2.79 (1.22) t(18) = −0.67, p = 0.512 −0.06 [−0.67, 0.55] t(16) = 0.57, p = 0.579 0.22 [−0.44, 0.87] Note: Baseline N = 72 (N iCBT = 49 and N control = 23), Post‐test N = 57 (N iCBT = 38 and N control = 19), Follow‐up N = 47 (N iCBT = 30 and N control = 17). Abbreviations: CWC, Cancer Worry Scale; HADS, Hospital Anxiety and Depression Scale; iCBT, internet‐delivered cognitive behavioural therapy; MOS‐SSS, Medical Outcomes Study Social Support Survey; QOL, Quality of Life Scale. *p < 0.05; **p < 0.01. AKKOL‐SOLAKOGLU AND HEVEY - 453 10991611, 2023, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/pon.6097, Wiley Online Library on [28/06/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License